User profiles for Paolo Gionchetti

Paolo Gionchetti

Professore Associato di Medicina Interna, DIMEC, Università di Bologna
Verified email at unibo.it
Cited by 34623

3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 1: diagnosis and medical management

…, F Rizzello, S Vavricka, P Gionchetti… - Journal of Crohn's …, 2017 - academic.oup.com
This paper is the first in a series of two publications relating to the European Crohn’s and
Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of …

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

P Gionchetti, F Rizzello, A Venturi, P Brigidi… - Gastroenterology, 2000 - Elsevier
Background & Aims: Pouchitis is the major long-term complication after ileal pouch-anal
anastomosis for ulcerative colitis. Most patients have relapsing disease, and no maintenance …

[PDF][PDF] Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations …

F Magro, P Gionchetti, R Eliakim… - Journal of Crohn's …, 2017 - academic.oup.com
1.2. Definitions Ulcerative colitis [UC] is a chronic inflammatory condition that causes continuous
mucosal inflammation of the colon, usually without granulomas on biopsy. It affects the …

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

P Gionchetti, F Rizzello, U Helwig, A Venturi… - Gastroenterology, 2003 - Elsevier
BACKGROUND & AIMS:: We have recently documented the efficacy of a highly concentrated
probiotic preparation (VSL#3) in the prevention of flare-up in patients with chronic pouchitis…

Once daily high dose probiotic therapy (VSL# 3) for maintaining remission in recurrent or refractory pouchitis

…, S Schreiber, IC Talbot, RJ Nicholls, P Gionchetti… - Gut, 2004 - gut.bmj.com
Background: Ten to 15% of patients with pouchitis experience refractory or recurrent disease.
The aim of this study was to evaluate the effectiveness of a single daily high dose probiotic …

ECCO guidelines on therapeutics in ulcerative colitis: medical treatment

…, C Fidalgo, G Fiorino, P Gionchetti… - Journal of Crohn's …, 2022 - academic.oup.com
Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic
inflammation extending to a variable extent from the rectum. Care of the patient with UC …

ECCO guidelines on therapeutics in Crohn's disease: medical treatment

…, F Furfaro, C Gingert, P Gionchetti… - Journal of Crohn's …, 2020 - academic.oup.com
2. Methods Based on the GRADE workflow, the Guidelines Committee of ECCO [GuiCom]
selected a panel of 48 experts supported by a team of methodologists and librarians. …

VSL# 3 probiotic-mixture induces remission in patients with active ulcerative colitis

…, GW Tannock, KL Madsen, P Gionchetti… - Official journal of the …, 2005 - journals.lww.com
METHODS Thirty-four ambulatory patients with active UC received open label VSL# 3,
3,600 billion bacteria daily in two divided doses for 6 wk. The presence of biopsy-associated …

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

…, DC Baumgart, G D'Haens, P Gionchetti… - Journal of Crohn's …, 2010 - academic.oup.com
Fistulating Crohn's disease (CD) comprises fistulae arising in the perianal area, together with
those communicating between the intestine and other organs or the abdominal wall. The …

European evidence based consensus on the diagnosis and management of Crohn's disease: current management

…, C Prantera, P Marteau, JF Colombel, P Gionchetti… - Gut, 2006 - gut.bmj.com
This second section of the European Crohn’s and Colitis Organisation (ECCO) Consensus
on the management of Crohn’s disease concerns treatment of active disease, maintenance of …